Skip to content

Generate Biomedicines, Inc. GENB Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

United Parcel Service, Inc. logo
United Parcel Service, Inc.UPS
$154M+14.1%
Williams Companies logo
Williams CompaniesWMB
$1.89B+13.8%
L3Harris Technologies logo
L3Harris TechnologiesLHX
$3.43B+14.8%
General Dynamics logo
General DynamicsGD
$3.19B+9.3%
The Travelers Companies logo
The Travelers CompaniesTRV
$261M+1.2%
PNC Financial Services logo
PNC Financial ServicesPNC
$238M-30.0%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's deferred tax assets and other non-current assets?
Generate Biomedicines, Inc. (GENB) reported deferred tax assets and other non-current assets of $4.75M in Q1 2026.